IgA nephropathy is a slowly progressing disease that causes kidney damage and leads to kidney failure in about 25-50% of patients. The reason why some people develop IgA nephropathy is unclear and there is no effective treatment.
Raphaël Duivenvoorden has now started a research project to unravel the cause of IgA nephropathy. It is of fundamental importance to gain a better understanding of the mechanisms leading to IgA nephropathy. The role of the gastrointestinal microbiome and immune cells in the bone marrow, are of particular interest for further research.
Therefore, in this research, Raphaël Duivenvoorden focuses on these two aspects to gain insight into how IgA nephropathy is caused. New insight into the cause of IgA nephropathy may contribute to the diagnosis of this disease and the development of targeted treatments. For more information, read here (in Dutch).
Related news items
Young Radboudumc researchers receive grant to engage in bio-medical and health research that is off the beaten path16 September 2021
The ZonMw Off Road program is once again giving young scientists the opportunity to conduct innovative research in medical and/or health care. This research is off the beaten track and aims to bring about new insights and unexpected breakthroughs for healthcare and healthcare innovation.read more
Infections increase risk to develop dementia16 September 2021
In a recently published study, Radboudumc researchers investigated the effects of infectious events on cognitive decline and the development of dementia and its possible structural underpinning using pre- and post-infection MRI of the brain.read more
ENABLECARES launches a course on entrepreneurship for PhD candidates and postdocs15 September 2021
Are you thinking about what to do after your PhD? Want to know more about entrepreneurship? This course gives you insight in many aspects of entrepreneurship and research in industry.read more
Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias15 September 2021
Lia Goltstein and colleagues published a study about effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis.read more